Alector Inc (STU:0Z2)
€ 3.98 -0.02 (-0.5%) Market Cap: 391.41 Mil Enterprise Value: -93.80 Mil PE Ratio: 0 PB Ratio: 2.37 GF Score: 62/100

Alector Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 08:40PM GMT
Release Date Price: €15.6 (+2.63%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

Welcome, everyone, to the 4:40 session on day 3 of the 42nd Annual Goldman Sachs Global Health Care Conference. My name is Graig Suvannavejh. I cover U.S. and European biopharma names here at the firm. And with that, it's my great pleasure to be hosting Alector today in a fireside chat. And joining us is Shehnaaz Suliman, who is COO, currently, still? Or have there been...

Shehnaaz Suliman
Alector, Inc. - President, COO & Interim Chief Business Officer

Yes, that's it, President and COO.

Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst

And with the company for almost -- was it almost 2 years?

Shehnaaz Suliman
Alector, Inc. - President, COO & Interim Chief Business Officer

2 years. Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot